Oral gefapixant reduces frequency of refractory or unexplained chronic coughs
1. Gefapixant 45 mg twice a day showed significant reductions in chronic cough over 12-24 weeks...
Read MoreApr 6, 2022
1. Gefapixant 45 mg twice a day showed significant reductions in chronic cough over 12-24 weeks...
Read MoreApr 5, 2022
1. In this systematic review of 37 studies, multiple barriers were identified in accessing...
Read MoreApr 2, 2022
1. In this study, patients who were obese or overweight had better survival compared to normal...
Read MoreApr 2, 2022
1. In this randomized clinical trial of 437 patients, no significant difference was observed in...
Read MoreApr 1, 2022
1. Rapid antigen tests detected persons with high SARS-CoV-2 levels, enabling rapid response to...
Read MoreApr 1, 2022
1. This large, prospective cohort study from Japan demonstrated an inverse association between the...
Read MoreMar 30, 2022
1. Aspirin cessation in older adults led to increased cardiovascular disease events, though not...
Read MoreMar 30, 2022
1. No changes in opioid or nonopioid pain prescribing patterns were attributable to state laws. 2....
Read MoreMar 30, 2022
1. There was no significant difference in the primary composite endpoint between the interatrial...
Read MoreMar 29, 2022
1. Single-dose liposomal amphotericin B followed by flucytosine and fluconazole was non-inferior...
Read MoreMar 29, 2022
1. Compared to trastuzumab emtansine, trastuzumab deruxtecan is associated with a lower risk of...
Read MoreMar 29, 2022
1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor...
Read MoreMar 28, 2022
Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive...
Read MoreMar 24, 2022
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series...
Read MoreMar 23, 2022
1. Homologous and heterologous booster vaccines had an acceptable safety profile in adults who...
Read MoreMar 23, 2022
1. In a cohort of about 80 adults who were born with very low birth weight (VLBW), total brain...
Read MoreMar 23, 2022
1. Both the Johnson & Johnson-Janssen (JJJ) and mRNA boosters provided an acceptable safety...
Read MoreMar 23, 2022
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared...
Read MoreMar 23, 2022
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema...
Read MoreMar 23, 2022
1. mRNA booster vaccines for Covid-19 were highly effective against delta infection but less...
Read More